Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 28 filings·Updated 13 Aug 2026
Showing 10 of 28 filings.
13 Aug 20261 filing
ResultFinancial Results

Bandaram Pharma Packtech Q2 FY2026: standalone loss Rs 35.68 lakh; consolidated profit Rs 68.44 lakh.

Standalone quarterly results

  • Standalone Q2 30.06.2026 revenue from operations: Rs 298.51 lakh.
  • Standalone Q2 30.06.2026 PBT: Rs -35.68 lakh.
  • Standalone Q2 30.06.2026 PAT: Rs -35.68 lakh.
  • Standalone Q2 30.06.2026 EPS (basic/diluted): Rs -0.20.

Consolidated quarterly results

  • Consolidated Q2 30.06.2026 revenue from operations: Rs 2,395.26 lakh.
  • Consolidated Q2 30.06.2026 PBT: Rs 92.49 lakh.
  • Consolidated Q2 30.06.2026 PAT: Rs 68.44 lakh.
  • Consolidated continuing EPS (basic): Rs 0.11; diluted: Rs 0.05.

Corporate actions & AGM

  • Independent Director Bommisetti reappointed for 2nd term from 07.03.2027.
  • Auditors M/s M.M. Reddy & Co. reappointed for 3 years.
  • Board approved unaudited results for Q2 2026 on 13 Aug 2026.
  • AGM scheduled 18.09.2026 via video conference.

Notes

  • Ind AS 34 interim reporting; results reviewed by statutory auditors.
  • Consolidated results include unaudited figures of VSR Paper & Craftsmart.
Filed 18:22View Source
6 Aug 20261 filing
Board Meeting

Bandaram Pharma Packtech to hold 13 August 2026 board meeting to review Q1 unaudited results

Meeting Details

  • Board meeting scheduled for 13 August 2026 at the registered office.

Key Agenda Items

  • Un-audited standalone and consolidated financial results with Limited Review Report for quarter ended 30.06.2026.
  • Any other business with the permission of the Chair.

Other Notes

  • Trading window closed from 01 July 2026 until 48 hours after the unaudited Q1 30 June 2026 results.
Filed 16:09View Source
11 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate confirms dematerialisation processing, listing, and registered owner update

Dematerialisation processing & records

  • Dematerialisation requests processed; securities listed on exchanges; certificates mutilated and cancelled; depository name substituted as registered owner.
Filed 13:18View Source
7 Jul 20261 filing
Company UpdateGeneral

Bandaram Pharma Packtech reports no material events or price-sensitive information

Movement in Price

  • No price-sensitive events or information; no extraordinary events occurred; will inform the Exchange if arising.
Filed 17:38View Source
6 Jul 20261 filing
Company UpdateClarification

The Exchange has sought clarification from Bandaram Pharma Packtech Ltd on July 6, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....

Filed 18:43
29 May 20263 filings
Company UpdateAward of Order / Receipt of Order

Bandaram Pharma Packtech Ltd - 524602 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

Order details

  • M/s S. A. Printers awarded the work order.
  • Scope covers paper, board, and other materials for printing and sale of textbooks.
  • Order is domestic.
  • Execution period is June to August 2026.
  • Order value is Rs. 3,86,85,410, for academic year 2026-27.
  • Value relates to printing and distribution of textbooks with paper and lamination.

Governance

  • No promoter or promoter group interest was reported in the awarding entity.
  • Related party transaction status was stated as not applicable.
Filed 15:46View Source
Company UpdateAward of Order / Receipt of Order

Bandaram Pharma Packtech Ltd - 524602 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

Order award

  • M/s Vijayaa Print Solutions awarded the work order.
  • VSR Paper and Packaging Limited will supply paper, board, and other materials for textbook printing and sale.
  • Order value is Rs. 5,86,97,217 for academic year 2026-27, including printing and distribution with paper and lamination.
  • The awarding entity is domestic.
  • Execution period is June to August 2026.
  • Promoter or group company interest was reported as none.
Filed 15:44View Source
Company UpdateAward of Order / Receipt of Order

Bandaram Pharma Packtech Ltd - 524602 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

Awarding entity

  • Government of Telangana awarded the work orders.

Contract scope

  • Printing and distribution of textbooks with paper and lamination for academic year 2026-27.

Order size

  • Aggregate order value is Rs. 37,44,33,407 for four orders.
  • Two disclosed work orders are worth Rs. 26,78,66,680 and Rs. 91,84,100.

Domestic status

  • The awarding entity is domestic.

Execution period

  • Execution is scheduled for June to August 2026.

Terms

  • Textbooks are to be available for sale from 1 June 2026.

Governance

  • No promoter or promoter group interest was reported in the awarding entity.
Filed 15:42View Source
27 Apr 20261 filing
AGM/EGMEGM

Bandaram Pharma Packtech Ltd - 524602 - Shareholder Meeting / Postal Ballot-Outcome of EGM

EGM purpose

  • Approved appointment of an independent director and two related-party transactions with subsidiary VSR Paper And Packaging Limited.

Resolutions

  • Special resolution: appointed Mr. Eswar Reddy Putturu as Independent Director; promoters were not interested.
  • Ordinary resolution: approved material related-party transaction with VSR Paper And Packaging Limited; promoters were interested.
  • Ordinary resolution: approved one-time material related-party transaction with VSR Paper And Packaging Limited; promoters were interested.

Voting outcome

  • All three resolutions passed unanimously among votes cast.
  • Resolution 1: 13,761,963 votes in favour, 0 against.
  • Resolution 2: 2,583,655 votes in favour, 0 against.
  • Resolution 3: 2,583,655 votes in favour, 0 against.

Shareholding and control

  • No direct change in share capital or control was disclosed.
  • Promoter group did not vote on the related-party resolutions.

Board changes

  • Mr. Eswar Reddy Putturu joined the board as an Independent Director.

Governance impact

  • Related-party approvals may support transactions with the subsidiary and affect intercompany dealings.
Filed 13:49View Source
3 Apr 20261 filing
OthersOutcome without intimation

Outcome of Board meeting to be held on 03.04.2026

Filed 13:23View Source
Showing 10 of 28 filings